Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Cheng Zhong1,2, Yirun Li1,2, Jing Yang1,2
1Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Frontiers in Oncology
|April 15, 2021
Summary
Immunotherapy shows promise for advanced hepatocellular carcinoma (HCC), offering potential benefits beyond traditional treatments. This review explores immune tolerance, therapeutic strategies, and challenges for HCC immunotherapy.
Area of Science:
- Oncology
- Immunology
- Hepatology
Background:
- Hepatocellular carcinoma (HCC) remains a significant health challenge with limited treatment options for advanced stages.
- Traditional therapies for HCC often yield suboptimal clinical benefits, especially in later disease progression.
Purpose of the Study:
- To review the current landscape of immunotherapy for hepatocellular carcinoma (HCC).
- To summarize key aspects of immune tolerance and immunotherapeutic strategies relevant to HCC.
- To identify and discuss the primary challenges associated with current HCC immunotherapeutic approaches.
Main Methods:
- Literature review focusing on immunotherapy in hepatocellular carcinoma.
- Synthesis of information on immune tolerance mechanisms in HCC.
- Analysis of existing and emerging immunotherapeutic strategies for HCC.
Main Results:
- Immunotherapy has demonstrated potential efficacy in various cancers and shows promise for advanced HCC.
- Current immunotherapeutic strategies face challenges related to immune tolerance and treatment resistance.
- Alternative approaches are being explored to enhance the effectiveness of HCC immunotherapy.
Conclusions:
- Immunotherapy represents a promising avenue for treating advanced hepatocellular carcinoma.
- Overcoming immune tolerance is crucial for successful HCC immunotherapy.
- Further research into novel strategies is needed to improve clinical outcomes for HCC patients.
Keywords:
epigenetic modificationhepatocellular carcinomaimmune toleranceimmunotherapytertiary lymphoid structuretumor microenvironmenttumor mutational burdenMore Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.6K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.4K
Related Concept Videos
01:27Tumor Immunotherapy
816
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
816
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
01:30Cancer Vaccines
605
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
605
02:49Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
02:50Combination Therapies and Personalized Medicine
5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K